Publicador de continguts
Recerca

ACROBAT-Newborns

Appraising the Critical Role of prognostic Biomarkers in the Assessment and Triage of sick African newborns: Advancing a point-of-care device based on sTREM-1 towards CE marking and implementation

Foto: Issouf Sanogo | gettyimages
Durada
01/01/2025 - 31/12/2029
Coordinador
Bàrbara Baro Sastre
Finançadors
EDCTP3

In sub-Saharan Africa, newborns face a high risk of severe illness and mortality, yet current methods for assessing infection severity often fall short, leading to misclassification and delayed care. The EU-funded ACROBAT Newborns project addresses this gap with the newly developed B-Triage, a rapid, point-of-care test that measures sTREM-1, a reliable biomarker for sepsis. This device provides a precise, independent prediction of illness severity across a range of conditions, helping prioritise care for the most vulnerable. The project will conduct clinical studies in Ethiopia, Gabon, Mozambique and Uganda, advancing B-Triage’s validation, industrialisation and market introduction in Africa. By improving healthcare resources, this innovation is aimed at improving survival rates and treatment outcomes for newborns.

 

Total Funding

4.808.065€

Our Team

Co-PIs

Equipo ISGlobal